Canadian Task Force on Preventive Health Care (current)* | Recommend against routine screening | Recommend against routine screening | Every 3 yr with cervical cytology | Every 3 yr with cervical cytology | Every 3 yr with cervical cytology if previous screening inadequate and until 3 negative results have been received; otherwise, screening may stop | No recommendation; will revisit the issue as new data become available |
Canadian Task Force on Preventive Health Care (1994) (15) | Every year with cervical cytology after start of sexual activity or at age 18 yr | After 2 normal Pap results, every 3 yr to age 69 yr; frequency may be increased in the presence of risk factors | After 2 normal Pap results, every 3 yr to age 69 yr; frequency may be increased in the presence of risk factors | After 2 normal Pap results, every 3 yr to age 69 yr; frequency may be increased in the presence of risk factors | Not recommended | Not applicable |
US Preventive Services Task Force (2012) (42) | Recommend against routine screening under age 21 yr | Recommend against routine screening under age 21 yr Every 3 yr with Pap testing ages 21–65 yr | Every 3 yr with Pap testing ages 21–65 yr | Every 3 yr with Pap testing ages 21–65 yr Recommend against screening for women older than age 65 yr who have had adequate prior screening and are not otherwise at high risk | Recommend against screening for women older than age 65 yr who have had adequate prior screening and are not otherwise at high risk | In combination with cytology (cotesting), every 5 yr for women ages 30–65 yr who want to lengthen the screening interval |
Government of Australia (2011) (43) | First Pap test at about 18–20 yr or 1 or 2 yr after first having sex, whichever is later | Every 2 yr with Pap testing | Every 2 yr with Pap testing | Every 2 yr with Pap testing | Practitioner may advise that it is safe to stop Pap testing if previous results have been normal | No recommendation |
National Health Service Cervical Screening Program, UK (2011) (41) | Not invited to screen | Not invited to screen | Every 3 yr with cytology for women aged 25–49 yr | Every 3 yr with cytology for women aged 25–49 yr Every 5 yr with cytology for women aged 50–64 yr Women aged ≥ 65 yr to undergo screening only if they have not had screening since age 50 yr, or they have had recent abnormal test results | Women aged ≥ 65 yr to undergo screening only if they have not had screening since age 50 yr, or they have had recent abnormal test results | Additional (triage) HPV testing is recommended for women ≥ 25 yr with abnormal test results in some circumstances |
Health Council of the Netherlands (2011) (88) | Not invited to screen | Not invited to screen | Not invited to screen | Every 5 yr for women aged 30–40 yr Every 10 yr for women aged 50–60 yr | Not invited to screen | HPV should replace cytology as the primary screening method; if using Pap test, triage HPV testing is recommended for women ≥ 30 yr with abnormal test results in some circumstances |
National Cancer Screening Service, Ireland (2011) (89) | Not invited to screen | Not invited to screen | Every 3 yr for women aged 25–44 yr Every 5 yr for women aged 45–60 yr (regardless of age at first screening, women must have 2 normal results 3 yr apart before moving to a 5-yr interval) | Every 3 yr for women aged 25–44 yr Every 5 yr for women aged 45–60 yr (regardless of age at first screeing, women must have 2 normal results 3 yr apart before moving to a 5- yr interval) | Not invited to screen | No recommendation |
National Health Service, Scotland (2010) (90) | Not invited to screen | Every 3 yr for women aged 20–60 yr | Every 3 yr for women aged 20–60 yr | Every 3 yr for women aged 20–60 yr | Not invited to screen | No recommendation |